European heart experts okay longer use of blood thinners

LONDON, Aug 29 (Reuters) - European heart experts on Saturday endorsed the potential use of multiple blood thinning drugs for heart attack patients beyond one year, in a move that may boost demand for AstraZeneca's Brilinta.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.